Clinical Trials Browser

Phase 1 × Recurrence × Erlotinib Hydrochloride × Clear all

NCT01515969 2016-07-12

Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung, Recurrence